Holen Sie sich die Stockscreener-App
64.44
0.44%
0.209
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt GEHC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$64.23
Offen:
$64.23
24-Stunden-Volumen:
2.15M
Relative Volume:
0.48
Marktkapitalisierung:
$29.32B
Einnahmen:
$20.98B
Nettoeinkommen (Verlust:
$1.98B
KGV:
15.43
EPS:
4.177
Netto-Cashflow:
$1.52B
1W Leistung:
+4.76%
1M Leistung:
-6.28%
6M Leistung:
-19.99%
1J Leistung:
-6.72%
1-Tages-Spanne:
$63.50
$65.09
1-Wochen-Bereich:
$61.00
$65.10
52-Wochen-Spanne:
$58.75
$89.77
Ge Healthcare Technologies Inc Stock (GEHC) Company Profile
Firmenname
Ge Healthcare Technologies Inc
Sektor
Branche
Telefon
833-735-1139
Adresse
500 WEST MONROE STREET, CHICAGO
Compare GEHC vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GEHC
Ge Healthcare Technologies Inc
|
64.46 | 29.22B | 20.98B | 1.98B | 1.52B | 4.177 |
ABT
Abbott Laboratories
|
86.64 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.20 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.82 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.72 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Ge Healthcare Technologies Inc Stock (GEHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-15 | Herabstufung | UBS | Neutral → Sell |
| 2025-10-13 | Eingeleitet | Barclays | Equal Weight |
| 2025-10-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-05 | Hochstufung | UBS | Sell → Neutral |
| 2025-03-11 | Hochstufung | Goldman | Neutral → Buy |
| 2025-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-09-26 | Herabstufung | UBS | Neutral → Sell |
| 2024-09-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-09-09 | Eingeleitet | JP Morgan | Neutral |
| 2024-08-06 | Eingeleitet | Stifel | Buy |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-02-15 | Eingeleitet | HSBC Securities | Buy |
| 2024-02-12 | Hochstufung | UBS | Sell → Neutral |
| 2023-11-30 | Eingeleitet | Jefferies | Hold |
| 2023-11-27 | Herabstufung | UBS | Neutral → Sell |
| 2023-09-19 | Eingeleitet | Citigroup | Buy |
| 2023-08-25 | Eingeleitet | Argus | Buy |
| 2023-08-16 | Eingeleitet | Wells Fargo | Overweight |
| 2023-07-31 | Eingeleitet | BofA Securities | Neutral |
| 2023-06-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-05-16 | Eingeleitet | Oppenheimer | Outperform |
| 2023-04-26 | Eingeleitet | UBS | Neutral |
| 2023-04-19 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-10 | Eingeleitet | BTIG Research | Neutral |
| 2023-03-13 | Eingeleitet | Evercore ISI | Outperform |
| 2023-02-17 | Eingeleitet | Mizuho | Buy |
| 2023-01-19 | Eingeleitet | Redburn | Buy |
Alle ansehen
Ge Healthcare Technologies Inc Aktie (GEHC) Neueste Nachrichten
GE HealthCare Faces Fresh Market Pressure Amid Healthcare Sector Volatility - Kalkine Media
GE HealthCare and UW Medicine Radiology Expand CT, MI Research Tie - The Globe and Mail
GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring a 23.98% Upside Potential - DirectorsTalk Interviews
GEHC launches MIM ComboTherapy for GYN cancer radiation planning - MSN
Is Wall Street bullish or bearish on GE HealthCare Technologies stock? - MSN
Securities Fraud Investigation Into GE HealthCare Technologies In - The National Law Review
GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - The Norfolk Daily News
GE HealthCare’s New AI Imaging Suite Tests Workflow And Revenue Potential - Yahoo Finance
GEHCGE HealthCare Technologies Inc Stock Price and Quote - Finviz
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - mydailyrecord.com
Here's why you should retain GEHC stock in your portfolio for now - MSN
GEHC Stock Price, Quote & Chart | GE HEALTHCARE TECHNOLOGY (NASDAQ:GEHC) - ChartMill
Law firm investigates GE HealthCare over Q1 earnings miss and lowered 2026 guidance. - Pluang
GEHC INVESTOR ALERT: Kirby McInerney LLP Investigates - GlobeNewswire
UBS Upgrades GE HealthCare Technologies(GEHC.US) to Hold Rating, Cuts Target Price to $69 - Moomoo
UBS Upgrades GE Healthcare Technologies to Neutral From Sell, Adjusts Price Target to $69 From $75 - Moomoo
GE HealthCare Offering Free Healthcare AI Training - dicardiology.com
UBS upgrades GE HealthCare Technologies (GEHC) - MSN
GE HealthCare Technologies Inc. (GEHC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
GE HealthCare Technologies Inc. stock rises Wednesday, outperforms market - MarketWatch
GE HealthCare Technologies Inc. (GEHC) Investigation: Bronstein - The National Law Review
GE HealthCare Technologies Inc.Common Stock (NQ: GEHC - The Chronicle-Journal
Deals tracker: Medtronic to acquire SPR Therapeutics for $650M - Modern Healthcare
With Strong Cash Flow, GE HealthCare Technologies Stock Poised to Rise? - Trefis
Linda Boltz Appointed Head of HR, Global Markets at GE HealthCare - hrtoday.in
Strong Cash Yield: Is GE HealthCare Technologies Stock A Buy? - Trefis
Bronstein, Gewirtz & Grossman, LLC Encourages GE HealthCare Technologies Inc. (GEHC) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
GEHC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving GE HealthCare Technologies Inc. - Business Wire
Law firm investigates GE HealthCare after Q1 earnings miss and stock drop - Pluang
Bragar Eagel & Squire, P.C. Continues Investigating GE - GlobeNewswire
Bragar Eagel & Squire, P.C. Continues Investigating GE HealthCare Technologies Inc. on Behalf of GE HealthCare Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Peter Arduini: Susquehanna Marketer, GE Healthcare Alumnus, and President and CEO of GE HealthCare - BBN Times
Bronstein, Gewirtz & Grossman, LLC Encourages GE HealthCare Techn - The National Law Review
GE HealthCare (GEHC) grants 16,458 RSUs to AIS CEO Philip Rackliffe - Stock Titan
GE HealthCare (GEHC) exec withholds 5,535 shares for RSU taxes - Stock Titan
AI in Health Care: 8 Stocks to Buy in 2026 | Investing - U.S. News Money
Argus Adjusts PT on GE Healthcare Technologies to $80 From $95, Maintains Buy Rating - Moomoo
Bronstein, Gewirtz & Grossman, LLC Is Investigating GE HealthCare Technologies Inc. (GEHC) And Encourages Shareholders to Connect - ACCESS Newswire
GE HealthCare Technologies Inc. stock rises Monday, outperforms market - MarketWatch
Bronstein, Gewirtz & Grossman, LLC Is Investigating GE HealthCare - The National Law Review
GE HealthCare hits one-year low as inflationary environment forces guidance cut - MSN
User - The Chronicle-Journal
FinancialContentGE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - FinancialContent
BTIG Reiterates GE HealthCare Technologies (GEHC) Buy Recommendation - MSN
GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Is a 31.58% Upside Within Reach? - DirectorsTalk Interviews
GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
GE HealthCare shares fall after earnings miss and lowered outlook - MSN
GE HealthCare Technologies (GEHC) price target decreased by 10.50% to 83.24 - MSN
GE HealthCare wins FDA 510(k) clearance for Photonova Spectra PCCT - MSN
GE HealthCare Technologies Sticks to Growth Story After Inflation-Driven Guidance Cut - Yahoo Finance
AASTOCKS Financial NewsGE HealthCare Technologies Inc. (GEHC) - AASTOCKS.com
Finanzdaten der Ge Healthcare Technologies Inc-Aktie (GEHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ge Healthcare Technologies Inc-Aktie (GEHC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Yang Watkin Phoebe L. | Director |
May 08 '26 |
Buy |
63.01 |
1,000 |
63,006 |
13,702 |
| CULP H LAWRENCE JR | Director |
May 06 '26 |
Buy |
61.88 |
80,805 |
5,000,076 |
151,207 |
| Stromberg William J | Director |
May 06 '26 |
Buy |
61.69 |
1,000 |
61,689 |
15,330 |
| SACCARO JAMES | Chief Financial Officer |
May 01 '26 |
Buy |
60.60 |
3,310 |
200,585 |
87,471 |
| Jimenez Frank R | GC & Corporate Secretary |
Apr 30 '26 |
Buy |
60.45 |
1,750 |
105,788 |
93,932 |
| Arduini Peter J | President and CEO |
Apr 30 '26 |
Buy |
59.92 |
4,169 |
249,827 |
259,424 |
0.17%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):